Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Geisinger Medical Center
mi
from
Danville, PA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Central Bucks Cardiology
mi
from
Doylestown, PA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Central Bucks Cardiology
mi
from
Doylestown, PA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Saint Vincent Health Care Center
mi
from
Erie, PA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Saint Vincent Health Care Center
mi
from
Erie, PA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Veterans Administration Medical Center
mi
from
Pittsburgh, PA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Veterans Administration Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Pinnacle Health System
mi
from
Harrisburg, PA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Pinnacle Health System
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Rhode Island Hospital
mi
from
Providence, RI
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
AnMed Health
mi
from
Anderson, SC
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Black Hills Cardiovascular Cardiology Associates P.C.
mi
from
Rapid City, SD
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Black Hills Cardiovascular Cardiology Associates P.C.
mi
from
Rapid City, SD
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Research Associates of Jackson
mi
from
Jackson, TN
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Research Associates of Jackson
mi
from
Jackson, TN
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
University of Tennessee
mi
from
Memphis, TN
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
University of Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Parkway Cardiology Associates
mi
from
Oak Ridge, TN
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Parkway Cardiology Associates
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
North Texas Healthcare System, Dept. of Veteran's Affairs
mi
from
Dallas, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
North Texas Healthcare System, Dept. of Veteran's Affairs
mi
from
Dallas, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Humble Cardiology Associates
mi
from
Humble, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Humble Cardiology Associates
mi
from
Humble, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Gamma Medical Research Inc.
mi
from
Mission, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Gamma Medical Research Inc.
mi
from
Mission, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Utah Cardiology PC
mi
from
Layton, UT
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Utah Cardiology PC
mi
from
Layton, UT
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
University of Vermont Medical Center, Fletcher Allen Health Care
mi
from
Burlington, VT
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
University of Vermont Medical Center, Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Cardiovascular Associates Ltd
mi
from
Virginia Beach, VA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Cardiovascular Associates Ltd
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Swedish Medical Center
mi
from
Seattle, WA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Intestinal Function in Neonates With Complex Congenital Heart Disease
Intestinal Function in Neonates With Complex Congenital Heart Disease
Status: Enrolling
Updated:  5/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Intestinal Function in Neonates With Complex Congenital Heart Disease
Intestinal Function in Neonates With Complex Congenital Heart Disease
Status: Enrolling
Updated: 5/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
NIRS-Based Cerebral Oximetry Monitoring in Elderly Thoracic Surgical Patients Undergoing Single Lung Ventilation Procedures: A Single Center, Prospective, Randomized Controlled Pilot Study Assessing the Clinical Impact of NIRS-Guided Intervention
Status: Enrolling
Updated:  5/28/2013
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
NIRS-Based Cerebral Oximetry Monitoring in Elderly Thoracic Surgical Patients Undergoing Single Lung Ventilation Procedures: A Single Center, Prospective, Randomized Controlled Pilot Study Assessing the Clinical Impact of NIRS-Guided Intervention
Status: Enrolling
Updated: 5/28/2013
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Cardiology PC
mi
from
Birmingham, AL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Florida
mi
from
Gainesville, FL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Pepin Heart Institute
mi
from
Tampa, FL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Pepin Heart Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Iowa Heart Center
mi
from
Des Moines, IA
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Iowa Heart Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Johns Hopkins University
mi
from
Baltimore, MD
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Spectrum Health
mi
from
Grand Rapids, MI
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Spectrum Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Washington University
mi
from
St. Louis, MO
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Montefiore Medical Center
mi
from
Bronx, NY
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Columbia University Medical Center
mi
from
New York, NY
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Summa Health System
mi
from
Akron, OH
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Baylor Healthcare
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Baylor Healthcare
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Utah
mi
from
Salt Lake City, UT
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
Comparison of the Effect of Ablation of the Clinically Presenting Ventricular Tachycardia (VT) Only Versus the Addition of Substrate Ablation Based on Scar Mapping; on the Long Term Success Rate of VT Ablation
Status: Enrolling
Updated:  6/4/2013
St.David's Medical Center
mi
from
Austin, TX
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
Comparison of the Effect of Ablation of the Clinically Presenting Ventricular Tachycardia (VT) Only Versus the Addition of Substrate Ablation Based on Scar Mapping; on the Long Term Success Rate of VT Ablation
Status: Enrolling
Updated: 6/4/2013
St.David's Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance
Double-Blind, Placebo Controlled Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance in Healthy Adult Humans
Status: Enrolling
Updated:  6/4/2013
Colorado State University, Dept. of Health and Exercise Science
mi
from
Fort Collins, CO
Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance
Double-Blind, Placebo Controlled Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance in Healthy Adult Humans
Status: Enrolling
Updated: 6/4/2013
Colorado State University, Dept. of Health and Exercise Science
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Measurement of the Quality of Pediatric CPR
Pediatric CPR Quality: Quantitative Measurement of Pediatric Cardiopulmonary Resuscitation (CPR) Quality During In-Hospital Cardiac Arrest
Status: Enrolling
Updated:  6/5/2013
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Measurement of the Quality of Pediatric CPR
Pediatric CPR Quality: Quantitative Measurement of Pediatric Cardiopulmonary Resuscitation (CPR) Quality During In-Hospital Cardiac Arrest
Status: Enrolling
Updated: 6/5/2013
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment in the Outpatient Setting
Status: Enrolling
Updated:  6/6/2013
Phoenix Children's Hospital Heart Failure Clinic
mi
from
Phoenix, AZ
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.
Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment in the Outpatient Setting
Status: Enrolling
Updated: 6/6/2013
Phoenix Children's Hospital Heart Failure Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated:  6/11/2013
Drexel University
mi
from
Philadelphia, PA
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated: 6/11/2013
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated:  6/11/2013
San Francisco VA Medical Center
mi
from
San Francisco, CA
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated: 6/11/2013
San Francisco VA Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography as Compared to Intravascular Ultrasound-Virtual Histology
Status: Enrolling
Updated:  6/13/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography as Compared to Intravascular Ultrasound-Virtual Histology
Status: Enrolling
Updated: 6/13/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Status: Enrolling
Updated:  6/15/2013
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Status: Enrolling
Updated: 6/15/2013
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Click here to add this to my saved trials
Cangrelor Prasugrel Transition Study
A Study of the Transition From IV Cangrelor to Oral Prasugrel, and Prasugrel to Cangrelor, in Patients With Coronary Artery Disease.
Status: Enrolling
Updated:  6/17/2013
Fletcher Allen Health Care
mi
from
Burlington, VT
Cangrelor Prasugrel Transition Study
A Study of the Transition From IV Cangrelor to Oral Prasugrel, and Prasugrel to Cangrelor, in Patients With Coronary Artery Disease.
Status: Enrolling
Updated: 6/17/2013
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated:  6/18/2013
The International Heart Institute of Montana
mi
from
Missoula, MT
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
The International Heart Institute of Montana
mi
from
Missoula, MT
Click here to add this to my saved trials